Encompass HealthMEX:EHC 88 PS Ratio is 1.17 as of Jul. 04, 2026, which is 13% below its 10-year median of 1.35. GuruFocus rates MEX:EHC with a GF Score™ of 88/100 and a GF Value™ of MXN1,344.64. The stock has 1 warning sign investors should review. Among 659 Healthcare Providers & Services companies, Encompass Health ranks worse than 54.93% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Encompass Health's share price is MXN1280.07517.
Encompass Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1,090.57. Hence, Encompass Health's PS Ratio for today is 1.17.
Good Sign:
Encompass Health Corp stock PS Ratio (=1.79) is close to 2-year low of 1.63.
The historical rank and industry rank for Encompass Health's PS Ratio or its related term are showing as below:
MEX:EHC'
s PS Ratio Range Over the Past 10 Years
Min: 0.86 Med: 1.35 Max: 2.28
Current: 1.79
During the past 13 years, Encompass Health's highest PS Ratio was 2.28. The lowest was 0.86. And the median was 1.35.
MEX:EHC's PS Ratio is ranked worse than 54.93% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs MEX:EHC: 1.79
Encompass Health Corp has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Encompass Health was 10.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 10.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 4.70% per year.
During the past 13 years, Encompass Health's highest 3-Year average Revenue per Share Growth Rate was 83.10% per year. The lowest was -27.00% per year. And the median was 8.20% per year.
Back to Basics: PS Ratio
Encompass Health (MEX:EHC) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Encompass Health PS Ratio Related Terms
Encompass Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Encompass Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Encompass Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encompass Health PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Encompass Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Encompass Health's Share Price of today is MXN1280.07517. Encompass Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,090.57.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Encompass Health (MEX:EHC) has a PS Ratio of 1.17 as of Jul. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Encompass Health and its competitors. This is 13% below median its historical median of 1.35. Over the past decade, Encompass Health's PS Ratio has ranged from 0.86 to 2.28. According to the industry distribution chart, Encompass Health ranks #362 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 54.9%.
Is Encompass Health's PS Ratio too high?
Encompass Health's current PS Ratio of 1.17 is 13% below median its 10-year median of 1.35. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 2.28. The Healthcare Providers & Services industry median PS Ratio is 1.52. Encompass Health's value of 1.17 is 23% below this industry median. Based on the distribution chart, Encompass Health ranks #362 out of 659 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Encompass Health has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's PS Ratio compare to ENSG and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #362 out of 659 companies for PS Ratio. This places Encompass Health in the lower half of its industry. The industry median PS Ratio is 1.52. Encompass Health's value of 1.17 is 23% below this benchmark. Historically, Encompass Health's own PS Ratio has ranged from 0.86 to 2.28 over the past decade. While the company's 10-year median is 1.35 vs. the industry median of 1.52, Encompass Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current PS Ratio of 1.17 is 23% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current PS Ratio is 1.17, which is 13% below median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Encompass Health (MEX:EHC) has a current PS Ratio of 1.17. The stock's GF Value™ is MXN1,344.64, compared to a current price of MXN1,280.08 — trading 4.8% below its estimated fair value. The current PS Ratio is 1.17, which is 13% below median its 10-year median of 1.35 and 23% below the Healthcare Providers & Services industry median of 1.52. Encompass Health's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current PS Ratio is 1.17 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encompass Health (MEX:EHC) Overvalued in 2026?
Based on GuruFocus' analysis, Encompass Health stock appears to be undervalued.
The current stock price of MXN1,280.08 is trading 4.8% below its estimated GF Value™ of MXN1,344.64.
Key valuation signals for MEX:EHC:
PS Ratio: 1.17 (13% below median its 10-year median of 1.35)
GF Value™: MXN1,344.64 vs. price of MXN1,280.08 (4.8% below fair value)
Industry Position: 23% below the Healthcare Providers & Services median (#362 of 659)
No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
88GF Score
Get the complete analysis for MEX:EHC
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EHC has been successfully added to your 
